Table 2:
Characteristics of Included Patients
| Characteristic | Proportion of Patients | 95% CI |
|---|---|---|
| Male | 77.2% | 74.0%−80.2% |
| Female | 22.0% | 19.1%−25.1% |
| Advanced-Stage (III-IV) Disease | 89.6% | 83.6%−94.3% |
| HPV-Positive | 37.2% | 17.4%−59.6% |
| HPV-Negative | 36.9% | 21.7%−53.5% |
| HPV-Unknown | 34.5% | 15.9%−56.1% |
| Tonsil Primary | 55.1% | 46.0%−64.0% |
| Lateral Pharyngeal Wall Primary | 39.0% | 13.2%−68.7% |
| Base of Tongue Primary | 38.5% | 30.7%−46.7% |
| Current/History of Alcohol Use | 60.1% | 46.3%−73.1% |
| No Alcohol Use | 39.7% | 26.8%−53.4% |
| Current/History of Tobacco Use | 71.8% | 61.2%−81.4% |
| No Tobacco Use | 27.7% | 18.3%−38.2% |
| Unknown Tobacco Use | 6.1% | 2.2%−11.8% |